1-(1,3-benzothiazol-2-yl)-4-{3-methoxy-4-[(prop-2-yn-1-yl)oxy]phenyl}-3-methyl-4,8-dihydro-1H-pyrazolo[3,4-e][1,4]thiazepin-7(6H)-one
Chemical Structure Depiction of
1-(1,3-benzothiazol-2-yl)-4-{3-methoxy-4-[(prop-2-yn-1-yl)oxy]phenyl}-3-methyl-4,8-dihydro-1H-pyrazolo[3,4-e][1,4]thiazepin-7(6H)-one
1-(1,3-benzothiazol-2-yl)-4-{3-methoxy-4-[(prop-2-yn-1-yl)oxy]phenyl}-3-methyl-4,8-dihydro-1H-pyrazolo[3,4-e][1,4]thiazepin-7(6H)-one
Compound characteristics
Compound ID: | D302-0032 |
Compound Name: | 1-(1,3-benzothiazol-2-yl)-4-{3-methoxy-4-[(prop-2-yn-1-yl)oxy]phenyl}-3-methyl-4,8-dihydro-1H-pyrazolo[3,4-e][1,4]thiazepin-7(6H)-one |
Molecular Weight: | 476.57 |
Molecular Formula: | C24 H20 N4 O3 S2 |
Smiles: | Cc1c2C(c3ccc(c(c3)OC)OCC#C)SCC(Nc2n(c2nc3ccccc3s2)n1)=O |
Stereo: | RACEMIC MIXTURE |
logP: | 4.4331 |
logD: | 4.4292 |
logSw: | -4.3913 |
Hydrogen bond acceptors count: | 7 |
Hydrogen bond donors count: | 1 |
Polar surface area: | 64.092 |
InChI Key: | DMBFIRXKWAUTNU-JOCHJYFZSA-N |